Q2 2025 Dishman Carbogen Amcis Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to Dishman Carbogen Amcis Limited Q2 FY25 earnings conference call. (Operator Instructions)
Please note that this conference is being recorded. I now hand the conference over to Mr. Pascal Villemagne. Thank you, and over to you, sir.
Thank you, moderator, and good afternoon, dear shareholders. I'm glad to be among you and [give] you a bit of feedback on what's happening during Q2 this year at Carbogen Amcis but also starting maybe with a bit of market updates. As you all know, our business is that is going through a kind of a difficult moment from a market perspective. A few of the venture capital are delaying the investment in new biotech funding in U.S. especially.
So we see a kind of a slight slowdown in capturing new business because the [Dishman money] is becoming a bit dry on the main markets. Hopefully, we've -- now the election of the new U.S. President, that phenomenon will stop, and there will be more investment in the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |